Tina Ventura
Chief Investor Relations Officer
Replay available
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
Chief Executive Officer
Chief Financial Officer
Analyst at UBS
Analyst at Goldman Sachs
Analyst at TD Cohen
Analyst at Piper Sandler
Analyst at Evercore
Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.297 Good day, and thank you for standing by. Welcome to Magical Pharmaceuticals' first quarter 00:00:05.297 -- 00:00:08.661 2025 earnings conference call. 00:00:08.661 -- 00:00:12.466 At this time, all participants are in a listen-only mode. 00:00:12.466 -- 00:00:17.412 After the speaker's presentation, there will be a question and answer session. 00:00:17.412 -- 00:00:21.357 As a reminder, today's conference call is being recorded. 00:00:21.357 -- 00:00:26.303 I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. 00:00:26.303 -- 00:00:28.723 Please go ahead. 00:00:28.806 -- 00:00:33.207 Thank you, Tawana. Good morning, everyone, and thank you for joining us to discuss Madrigal's 00:00:33.207 -- 00:00:35.790 first quarter 2025 earnings. 00:00:35.790 -- 00:00:39.433 We issued a press release this morning, and I have a slide deck that accompanies this 00:00:39.433 -- 00:00:43.597 webcast, which we'll post on the investor relations section of our website right after 00:00:43.597 -- 00:00:45.579 the call. 00:00:45.579 -- 00:00:49.983 On the call with me today is Bill Sibyl, Chief Executive Officer, and Marty Deer, Chief 00:00:49.983 -- 00:00:55.088 Financial Officer. They'll provide prepared remarks, and then we'll take your questions. 00:00:55.088 -- 00:00:58.452 We plan to keep today's call to about 45 minutes. 00:00:58.452 -- 00:01:03.243 Please note on slide two, We will be making certain forward-looking statements today. 00:01:03.243 -- 00:01:08.572 We refer you to our SEC filings for a discussion of the risks that may cause actual 00:01:08.572 -- 00:01:12.179 results to differ from the forward-looking statements. 00:01:12.179 -- 00:01:16.266 With that, I will now turn the call over to Bill on slide three. ...